Omeros Corporation
OMER
#6798
Rank
A$0.93 B
Marketcap
A$13.25
Share price
-4.73%
Change (1 day)
11.28%
Change (1 year)

Omeros Corporation (OMER) - Cash on Hand

Cash on Hand as of September 2025 : A$54.53 Million

According to Omeros Corporation's latest financial reports the company has A$54.53 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Omeros Corporation - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.14 B-42.55%
2023-12-31A$0.25 B-11.94%
2022-12-31A$0.28 B32.04%
2021-12-31A$0.21 B23.6%
2020-12-31A$0.17 B102.15%
2019-12-31A$86.82 M1.1%
2018-12-31A$85.87 M-19.95%
2017-12-31A$0.10 B70.58%
2016-12-31A$62.88 M62.1%
2015-12-31A$38.79 M361.1%
2014-12-31A$8.41 M-46.78%
2013-12-31A$15.8 M-26.5%
2012-12-31A$21.5 M-10.25%
2011-12-31A$23.96 M-42.04%
2010-12-31A$41.34 M-38.42%
2009-12-31A$67.13 M137.03%
2008-12-31A$28.32 M2.82%
2007-12-31A$27.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
A$4.6 M-91.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
A$1.03 M-98.11%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
A$22.64 B 41,424.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$28.05 B 51,339.66%๐Ÿ‡บ๐Ÿ‡ธ USA